Madrigal Pharmaceuticals reports for 202124.02.2022 at 16:19Сергей НовиковNews editorpress@blackterminal.comMadrigal Pharmaceuticals' GAAP loss for 2021 was $241.846 million, up 19.6% from $202.244 million in the previous year. Madrigal PharmaceuticalsMDGL215.6 USD-0.26%ReviewSource: ir.madrigalpharma.com
